Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001615219-19-000047
Filing Date
2019-09-18
Accepted
2019-09-18 16:55:45
Documents
6
Period of Report
2019-07-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A slrx8kano1.htm 8-K/A 988807
2 EX-23.1 a231weaverconsentng.htm EX-23.1 4055
3 EX-99.1 a991salarius12-31x18fs.htm EX-99.1 371779
4 EX-99.2 a992salarius6-30x19fs.htm EX-99.2 299389
5 EX-99.4 a994proformafs.htm EX-99.4 292259
6 EX-99.3 a993salarius3-31x19fs.htm EX-99.3 264058
  Complete submission text file 0001615219-19-000047.txt   2221554
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36812 | Film No.: 191100271
SIC: 2834 Pharmaceutical Preparations